Cyclo Therapeutics Inc (NASDAQ: CYTH) started the day on Thursday, with a price increase of 11.83% at $1.04, before settling in for the price of $0.93 at the close. Taking a more long-term approach, CYTH posted a 52-week range of $0.55-$1.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 7.56%. Meanwhile, its Annual Earning per share during the time was -88.22%. This publicly-traded company’s shares outstanding now amounts to $28.77 million, simultaneously with a float of $12.38 million. The organization now has a market capitalization sitting at $29.76 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7144, while the 200-day Moving Average is $0.9420.
Cyclo Therapeutics Inc (CYTH) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Cyclo Therapeutics Inc’s current insider ownership accounts for 56.73%, in contrast to 10.96% institutional ownership.
Cyclo Therapeutics Inc (CYTH) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Cyclo Therapeutics Inc (NASDAQ: CYTH) Trading Performance Indicators
Let’s observe the current performance indicators for Cyclo Therapeutics Inc (CYTH). It’s Quick Ratio in the last reported quarter now stands at 0.16. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 34.20.
In the same vein, CYTH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.90.
Technical Analysis of Cyclo Therapeutics Inc (CYTH)
If we take a close look at the recent performances of Cyclo Therapeutics Inc (NASDAQ: CYTH), its last 5-days Average volume was 17.71 million that shows progress from its year to date volume of 3.1 million. During the previous 9 days, stock’s Stochastic %D was recorded 33.52% While, its Average True Range was 0.1444.
Raw Stochastic average of Cyclo Therapeutics Inc (CYTH) in the period of the previous 100 days is set at 54.44%, which indicates a major rise in contrast to 45.17% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 225.57% that was higher than 111.51% volatility it exhibited in the past 100-days period.
